Clinical Trials Logo

Clinical Trial Summary

Fibromuscular dysplasia (FMD) is localized structural defects in the arterial wall, whose innate or acquired character is still unknown. This segmental non atheromatous injury, leads to stenosis of the arteries of small and medium caliber. Renal arteries are the most commonly affected with 60-75% of total fibrodysplasia. Three histological subtypes have been described: intimal, medial and peri-medial. They are not mutually exclusive and can be observed in the same patient.

This is a rare blood disease, occurring in children and young adults. In this young population with long life expectancy, these aneurysmal lesion are associated with 10% risk of rupture. To date, no data have shown in the literature that FMD is link to genetic causes, or if there is specific histopathologic lesions for non-atherosclerotic renal artery aneurysms.

To answer these questions, Cardiovascular Surgery Unit of the University Hospital of Saint-Etienne, French national reference center for renal artery surgery, in association with the Reference Center for Rare Vascular Disease in Paris, designed the first study for pathological and genetic characteristics of dysplastic renal artery aneurysms in young patients.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT02528149
Study type Observational
Source Centre Hospitalier Universitaire de Saint Etienne
Contact
Status Completed
Phase N/A
Start date September 2013
Completion date December 2014

See also
  Status Clinical Trial Phase
Completed NCT02476526 - Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease Phase 4
Completed NCT00209391 - A Safety & Efficacy Clinical Study to Evaluate the Narrowing of the Renal Arteries While Using Gadodiamide Phase 3
Completed NCT01673373 - Renal Stent Placement for the Treatment of Renal Artery Stenosis in Patients With Resistant Hypertension N/A
Completed NCT02266394 - Hypoxia and Inflammatory Injury in Human Renovascular Hypertension Phase 1
Recruiting NCT02388139 - Cardiovascular, Renal and Metabolic Profile in Patients With Acute Myocardial Infarction (REN-ACS) N/A
Active, not recruiting NCT01023373 - Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy Phase 4
Recruiting NCT05603221 - Renal Perfusion Assessment in the Endovascular Treatment of Renal Artery Stenosis
Recruiting NCT03252639 - A Study of Using Parenchymal Blood Volume(PBV) for Endovascular Treatment of Renal Arterial Stenosis N/A
Completed NCT00235157 - A Comparison of Coated and Uncoated Stents in Renal Artery Treatment. Phase 2
Completed NCT00001313 - Evaluation of Patients With Known or Suspected Heart Disease N/A
Not yet recruiting NCT05612438 - RADIX 2 RENAL STENT Post-Market Retrospective Study
Withdrawn NCT03914157 - Ultrasound Wave Therapy for Post-stenotic Microvascular Remodeling N/A
Completed NCT01128933 - Renal Fractional Flow Reserve in Renal Artery Stenting N/A
Recruiting NCT03594786 - Impact of Supra-renal Fixation of EVAR on Hemodynamics of Renal Arteries N/A
Completed NCT00885768 - Prevalence of Renal Artery Stenosis in Patients Referred for Cardiac Catheterization Phase 3
Completed NCT04423458 - Evaluation of Advanced US Tools in Assessing Allograft Complications
Recruiting NCT02655341 - Hydration Status Assessment Through Body Composition Monitoring in Patients With Acute Myocardial Infarction N/A
Completed NCT01576835 - Renal Artery Contrast-Free Trial Phase 4
Completed NCT01057316 - Formula PTX Renal Stent Clinical Study N/A
Completed NCT00631540 - REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent N/A